Answers are grounded in this paper and cite their sources.
Proteomic organ-specific aging clocks have shown promise in quantifying age-related risks, yet their generalizability to non-European populations and their biological underpinnings remain poorly characterized. This study evaluated organismal and 11 organ-specific clocks based on SomaScan v5.0 proteomics in 185 Chinese adults from the Hong Kong Osteoporosis Study enriched for high and low bone mineral density. Over a median follow-up of 20.3 years, muscle aging was associated with incident chronic kidney disease after FDR correction (HR per SD increase=2.84, 95% CI = 1.51–5.34). Several additional organ-concordant associations were observed at nominal significance ( P < 0.05) and consistent with prior literature, including heart aging with ischemic heart disease (HR = 1.50, 95% CI = 1.00–2.25), adipose aging with diabetes (HR = 1.56, 1.05–2.31), and lung aging with chronic obstructive pulmonary disease (HR = 3.77, 1.33–10.69). Immune (HR = 1.95) and brain aging (HR = 1.73) were also associated with all-cause mortality after FDR correction. Notably, individuals with ≥3 vs. no aged organs had a 16.5-fold higher mortality risk (95% CI = 5.34–50.78). Metabolome-wide analyses identified 380 metabolites associated with ≥1 organ age gap at FDR < 0.05, with taurine-hypotaurine metabolism pathway enriched across multiple organs. Mendelian randomization analysis further identified four statistically significant associations, including an inverse association of genetically predicted hypotaurine with brain aging. These findings provide supportive evidence for the applicability of organ-specific proteomic clocks in this Chinese cohort and implicate taurine-hypotaurine metabolism in the proteomic signatures of multi-organ aging.
No takes yet. Share an insight, caveat, or question.
Mak et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: